[BIO] Bio-Rad Laboratories, Inc.

Overview

Type of security: Stock

Sector: Capital Goods

Industry: Biotechnology: Laboratory Analytical Instruments

Market Capitalization:

Exchange: NYSE

The data is delayed by 15 minutes.

 

Price: 183.48 Change: 0.83 (0.45%)
Ext. hours: Change: 0 (0%)

chart BIO

Refresh chart

Strongest Trends Summary For BIO

BIO is in the long-term up 167% in 7 years.

Horizon: 3 hours | 2 days | 5 days | 10 days | 1 month | 6 months | 1 year | 2 years | 5 years | max

Chart type: absolute | relative to S&P

Publish chart

 

Description: Bio-Rad Laboratories, Inc. manufactures and supplies products and systems used to separate complex chemical and biological materials, as well as to identify, analyze, and purify their components for life science research, healthcare, analytical chemistry, and other markets. The company operates through two segments, Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes. It focuses on selected segments of the life sciences market in proteomics, genomics, biopharmaceutical production, cell biology, and food safety. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology researchers, food producers, and food testing laboratories. The Clinical Diagnostics segment designs, manufactures, sells, and supports test sy

Fundamental Ratios
Shares Outstanding EPS2.61 EPS Growth - 4 Quarters EPS Growth - Q/Q
EPS Growth - Y/Y Sales Growth - 4 Quarters -11.92% Sales Growth - Q/Q-20.96% P/E84.52
P/E To EPS Growth P/S P/BV Price/Cash Per Share
Price/Free Cash Flow ROA3.01% ROE4.55% ROI3.44%
Current Ratio4.08 Quick Ratio2.93 Long Term Debt/Equity0.34 Debt Ratio0.19
Gross Margin54.87% Operating Margin7.66% Net Profit Margin4.68% Dividend Payout Ratio
Dividend Yield
Fundamental Data
Cash From Financing Activities-330 K Cash From Investing Activities-27.99 M Cash From Operating Activities29.45 M Gross Profit270.11 M
Net Profit17.82 M Operating Profit34.35 M Total Assets3.33 B Total Current Assets1.7 B
Total Current Liabilities416.88 M Total Debt435.93 M Total Liabilities1.13 B Total Revenue472.82 M
Technical Data
High 52 week317.41 Low 52 week233.97 Last close296.72 Last change-0.85%
RSI48.26 Average true range9.52 Beta0.73 Volume71.23 K
Simple moving average 20 days-0.93% Simple moving average 50 days-2.38% Simple moving average 200 days5.89%
Performance Data
Performance Week-4.62% Performance Month1.68% Performance Quart9.76% Performance Half2.09%
Performance Year10.07% Performance Year-to-date-3.49% Volatility daily1.85% Volatility weekly4.13%
Volatility monthly8.46% Volatility yearly29.32% Relative Volume236.57% Average Volume249.47 K
New High0.51% New Low

News

2019-10-12 15:34:00 | Here’s What Hedge Funds Think About Bio-Rad Laboratories, Inc. BIO

2019-10-08 10:36:02 | LabCorp LH Names Two Leaders for Major Business Wings

2019-10-07 06:36:10 | Bruker To Buy Freiberg Instruments' Magnettech EPR Business

2019-10-02 09:48:01 | Abbott ABT Gets FDA Nod for New Troponin-I Blood Test

2019-10-01 17:10:41 | It's not just Google: 'Fierce' competition for tech talent is pushing median salaries past $200K at many Silicon Valley companies

2019-09-18 09:07:09 | Goldman Sachs: 4 Conviction Buy Stocks To Snap Up Now

2019-09-12 17:28:48 | After record IPO, East Bay company's CEO targets growth — and sleep

2019-09-12 09:55:33 | On eve of biggest biotech IPO this year, 2 East Bay companies spar over patents

2019-09-11 17:48:00 | Bio-Rad Files New Lawsuit Against 10X Genomics for Patent Infringement

2019-08-31 09:31:01 | Bio-Rad BIO Up 8.8% Since Last Earnings Report: Can It Continue?

2019-08-29 18:13:45 | Biome Sees Revenue Quadruple, Gross Profits Triple In Q2

2019-08-29 15:20:07 | Edited Transcript of BIO earnings conference call or presentation 1-Aug-19 9:00pm GMT

2019-08-23 06:51:10 | Here's Why You Should Retain Bio-Rad BIO Stock for Now

2019-08-21 18:56:00 | Fitch Ratings Upgrades Bio-Rad to BBB, ‘Outlook Stable,’ Reflecting Continued Improvement in the Company’s Operating Performance

2019-08-19 17:45:47 | How a biotech revolution catapulted this East Bay company to a $100M IPO

2019-08-13 07:00:00 | The $200K Club: NetApp's median employee gets a pay boost to join the salary ranks of Google, Netflix and Facebook

2019-08-09 09:30:01 | PRGO vs. BIO: Which Stock Is the Better Value Option?

2019-08-02 09:15:01 | Bio-Rad Bio Q2 Earnings Beat Estimates, Margins Expand

2019-08-01 20:26:34 | Bio-Rad Laboratories Inc BIO BIO-B Q2 2019 Earnings Call Transcript

2019-08-01 18:15:10 | Bio-Rad Laboratories BIO Surpasses Q2 Earnings and Revenue Estimates

2019-08-01 16:15:00 | Bio-Rad Reports Second-Quarter 2019 Financial Results

2019-07-30 12:20:38 | Do Insiders Own Shares In Biome Grow Inc. CNSX:BIO?

2019-07-25 10:33:02 | Analysts Estimate Bio-Rad Laboratories BIO to Report a Decline in Earnings: What to Look Out for

2019-07-24 21:52:00 | Delaware District Court Grants Bio-Rad’s Motion for Permanent Injunction Against 10X Genomics

2019-07-23 20:46:00 | Bio-Rad to Report Second-Quarter 2019 Financial Results

2019-07-18 09:19:01 | IVD Market Sustains Momentum: 3 Stocks in Focus

2019-07-15 09:12:01 | ABT or BIO: Which Stock Has Better Potential Right Now?

2019-07-08 07:30:00 | Facebook churns out a per-employee profit of $635K per year. How that compares with Apple, Google, Cisco, Oracle, Salesforce and others

2019-07-04 09:06:01 | Here's Why You Should Invest in CONMED CNMD Stock Now

2019-07-03 09:41:01 | Luminex LMNX Presents ARIES MRSA Assay to FDA for Clearance

2019-07-01 17:43:06 | Bio-Rad Laboratories, Inc. -- Moody's announces completion of a periodic review of ratings of Bio-Rad Laboratories, Inc.

2019-06-27 19:34:00 | Moody’s Upgrades Bio-Rad to Baa2, Reflecting Recent Improvement in the Company’s Operating Performance

2019-06-27 15:35:08 | Bio-Rad Laboratories, Inc. -- Moody's upgrades Bio-Rad to Baa2, outlook is stable

2019-06-14 08:29:11 | Here’s What Hedge Funds Think About Bio-Rad Laboratories, Inc. BIO

2019-06-14 06:53:06 | What Kind Of Shareholder Appears On The BIOTON S.A.'s WSE:BIO Shareholder Register?

2019-06-12 07:30:00 | 9 major Bay Area tech employers pay a typical worker more than $200K per year

2019-06-10 08:08:05 | See what the IHS Markit Score report has to say about Bio Rad Laboratories Inc.

2019-06-07 09:30:01 | Bio-Rad BIO Down 6.9% Since Last Earnings Report: Can It Rebound?

2019-06-03 14:03:00 | Bio-Rad to Participate in Goldman Sachs Annual Global Healthcare Conference on June 11

2019-05-31 08:09:12 | Here's Why You Should Retain Bio-Rad BIO Stock For Now

2019-05-24 12:00:32 | When Will Biome Grow Inc. CNSX:BIO Become Profitable?

2019-05-23 16:09:00 | Bio-Rad to Participate at Jefferies 2019 Global Healthcare Conference on June 4

2019-05-09 09:03:01 | Bio-Rad BIO Q1 Earnings Beat Estimates, Margins Expand

2019-05-08 21:36:50 | Edited Transcript of BIO earnings conference call or presentation 8-May-19 9:00pm GMT

2019-05-08 20:23:55 | Bio-Rad Laboratories Inc BIO Q1 2019 Earnings Call Transcript

2019-05-08 19:05:11 | Bio-Rad Laboratories BIO Q1 Earnings and Revenues Beat Estimates

2019-05-08 18:00:38 | Bio-Rad: 1Q Earnings Snapshot

2019-05-08 16:15:00 | Bio-Rad Reports First Quarter 2019 Financial Results

2019-05-07 10:38:02 | Will Life Sciences Sales Boost Bio-Rad's BIO Q1 Earnings?

2019-05-07 08:06:52 | See what the IHS Markit Score report has to say about Bio Rad Laboratories Inc.